Clinical Trials Browser

Breast Neoplasms × pyrotinib × 30 days × Clear all

NCT07417241 2026-02-18

SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study

Phase 2 Not yet recruiting

Breast Neoplasms